drugset / Trial / NCT02605707
Autologous Endothelial Progenitor Cells Transplantation for Chronic Ischemic Stroke
Phase 1/2
Completed
12 enrolled
Southern Medical University, China
Second Affiliated Hospital of Guangzhou Medical University · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
Stroke is a frequently occurring and common diseases in nervous system,and most of the survivors will remain disorders of motor,sensory and cognition function.Stem cell transplantation provides a promising approach for rehabilitation. The main objective of this study is to evaluate the efficacy and safy of the transplantation of autologous endothelial progenitor cells in patients with chronic stroke.
Timeline
- Start
- 2014-11
- Primary completion
- 2017-12
- Completion
- 2020-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | autologous endothelial progenitor cells | Unknown | — | Intravenous |